Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Sengoku K et al. Effects of platelet activating factor on human sperm function in vitro. 1993 Hum. Reprod. pmid:8253933
Nathan N and Denziot Y Platelet-activating factor and nonalcoholic cirrhotics. 1993 Gastroenterology pmid:8253376
Hotchkiss JA et al. Platelet activating factor stimulates rapid mucin secretion in rat nasal airways in vivo. 1993 Sep-Oct Exp. Lung Res. pmid:8253058
Archer CB Platelet activating factor--a mediator of inflammation in the skin--medical implications. 1993 Clin. Exp. Dermatol. pmid:8252783
Imai T et al. [Relation of platelet activating factor induced airway hyperresponsiveness to thromboxane A2 and neutrophil in dogs]. 1993 Arerugi pmid:8250720
Zhang B and Long K Effects of glaucocalyxin A on aggregation and cAMP levels of rabbit platelets in vitro. 1993 Zhongguo Yao Li Xue Bao pmid:8249632
Zeng GQ et al. Dauricine and anisodamine inhibited leukotrienes- and platelet activating factor-induced DNA synthesis and proliferation of bovine cerebral microvascular smooth muscle cells in culture. 1993 Zhongguo Yao Li Xue Bao pmid:8249627
Musemeche CA et al. Intestinal ischemia in the newborn: the role of intestinal maturation. 1993 J. Surg. Res. pmid:8246492
Duque I et al. Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells. 1993 J. Pharmacol. Exp. Ther. pmid:8246135
van der Bruggen T et al. Transient exposure of human eosinophils to the protein kinase C inhibitors CGP39-360, CGP41-251, and CGP44-800 leads to priming of the respiratory burst induced by opsonized particles. 1993 J. Leukoc. Biol. pmid:8245706
McDonald PP et al. Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. 1993 J. Immunol. pmid:8245474
Emmendörffer A et al. Production of oxygen radicals by fibroblasts and neutrophils from a patient with x-linked chronic granulomatous disease. 1993 Eur. J. Haematol. pmid:8243611
Hu W et al. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. 1993 Br. J. Pharmacol. pmid:8242237
Bkaily G et al. PAF activation of a voltage-gated R-type Ca2+ channel in human and canine aortic endothelial cells. 1993 Br. J. Pharmacol. pmid:8242226
Eda R et al. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation. 1993 Int. Arch. Allergy Immunol. pmid:8241801
Saito H et al. Platelet-activating-factor-induced augmentation of production of eosinophil-lineage cells in hematopoietic precursor cells obtained from human umbilical cord blood. 1993 Int. Arch. Allergy Immunol. pmid:8241800
Perez SA et al. Eosinophil granulocyte proliferation induced by an intermediate factor generated in the pleural cavity of rats injected with platelet-activating factor-acether. 1993 Int. Arch. Allergy Immunol. pmid:8241799
Rochon YP and Frojmovic MM Regulation of human neutrophil aggregation: comparable latent times, activator sensitivities, and exponential decay in aggregability for FMLP, platelet-activating factor, and leukotriene B4. 1993 Blood pmid:8241512
Laneuville O et al. Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4. 1993 Biochem. J. pmid:8240236
Fletcher JR Eicosanoids. Critical agents in the physiological process and cellular injury. 1993 Arch Surg pmid:8239981
Weintraub ST et al. Synthesis of pentafluorobenzoic anhydride: a superior derivatizing agent for lipids. 1993 Anal. Chem. pmid:8238933
Ma Y et al. [PAF antagonistic benzofuran neolignans from Piper kadsura]. 1993 Yao Xue Xue Bao pmid:8237383
Krämer K et al. Studies on the metabolism of metallothionein and alkaline phosphatase of adult rat primary hepatocyte cultures: role of fetal calf serum and agonists of the phosphoinositide cascade. 1993 Z Ernahrungswiss pmid:8237077
Nobe K et al. Effect of diacylglycerol kinase inhibitor, R59022 on cytosolic free calcium level and force development in guinea pig taenia coli. 1993 Res. Commun. Chem. Pathol. Pharmacol. pmid:8235067
Kojima T et al. Production and secretion of progesterone in vitro and presence of platelet activating factor (PAF) in early pregnancy of the marsupial, Macropus eugenii. 1993 Reprod. Fertil. Dev. pmid:8234890
Kim YD et al. Constriction of canine coronary arteries by platelet activating factor after brief ischemia. 1993 Prostaglandins pmid:8234834
Capasso F et al. Effect of senna is not mediated by platelet-activating factor. 1993 Pharmacology pmid:8234442
Furukawa M et al. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. 1993 Pediatr. Res. pmid:8233731
MacKendrick W et al. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. 1993 Pediatr. Res. pmid:8233729
Green PG et al. Trypsin enhances sympathetic neuron-dependent plasma extravasation in the rat knee joint. 1993 Neurosci. Lett. pmid:8233065
Green PG et al. Further substantiation of a significant role for the sympathetic nervous system in inflammation. 1993 Neuroscience pmid:8232896
Satouchi K et al. Phospholipids from the free-living nematode Caenorhabditis elegans. 1993 Lipids pmid:8231660
Ko W et al. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion. 1993 J. Surg. Res. pmid:8231170
Bull DA et al. Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. 1993 J. Surg. Res. pmid:8231165
Houlihan WJ et al. Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists. 1993 J. Med. Chem. pmid:8230095
Rocha FA et al. Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry. 1993 J. Rheumatol. pmid:8230022
Müller-Peddinghaus R et al. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics. 1993 J. Pharmacol. Exp. Ther. pmid:8229782
Jeanneton O et al. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved. 1993 J. Pharmacol. Exp. Ther. pmid:8229757
Teixeira MM et al. Mechanisms of the inflammatory response induced by extracts of Schistosoma mansoni larvae in guinea pig skin. 1993 J. Immunol. pmid:8228243
Mangino MJ et al. Characterization of platelet-activating factor receptors on canine T lymphocytes. 1993 J. Immunol. pmid:8228226
Minor T and Isselhard W Platelet-activating factor antagonism enhances the liver's recovery from warm ischemia in situ. 1993 J. Hepatol. pmid:8228131
Silvestro L et al. Development of a high-performance liquid chromatographic-mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samples. 1993 J. Chromatogr. pmid:8227267
Garcia Rodriguez C et al. Dissociation of platelet-activating factor production and arachidonate release by the endomembrane Ca(2+)-ATPase inhibitor thapsigargin. Evidence for the involvement of a Ca(2+)-dependent route of priming in the production of lipid mediators by human polymorphonuclear leukocytes. 1993 J. Biol. Chem. pmid:8227034
Persico P et al. Protective effect of SV-IV on platelet-activating factor-induced hypotension, bronchoconstriction and gastric mucosal injury. 1993 Eur. J. Pharmacol. pmid:8223928
Itoh K et al. Effects of CS-518, a thromboxane synthase inhibitor, on eosinophil function. 1993 Eur. J. Pharmacol. pmid:8223890
Morita M et al. Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukaemia cell line EoL-1. 1993 Curr Med Res Opin pmid:8222744
Hurst JS and Bazan HE The platelet-activating factor precursor of the injured cornea is selectively implicated in arachidonate and eicosanoid release. 1993 Curr. Eye Res. pmid:8222725
Hagar AF et al. Endotoxin infusion primes elicited neutrophils and Kupffer cells for platelet-activating factor-induced and tripeptide formyl-methionine-leucine-phenylalanine-induced basal free intracellular calcium concentration responses. 1993 Crit. Care Med. pmid:8222693
Katoh S et al. Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309. 1993 Cardiovasc. Res. pmid:8221795
Austin CE and Foreman JC The effect of platelet-activating factor on the responsiveness of the human nasal airway. 1993 Br. J. Pharmacol. pmid:8220870
Seeds EA et al. The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration. 1993 J Lipid Mediat pmid:8219006
Qian C et al. Platelet-activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs. 1993 J Lipid Mediat pmid:8219003
Weintraub ST et al. Differential electron capture mass spectral response of pentafluorobenzoyl derivatives of platelet activating factor alkyl chain homologs. 1993 Biol. Mass Spectrom. pmid:8218422
Tsoukatos DC et al. Studies on the subcellular distribution of 1-O-alkyl-2-acetyl-sn-glycero phosphocholine (PAF) and on the enzymic activities involved in its biosynthesis within the ciliate Tetrahymena pyriformis. 1993 Biochim. Biophys. Acta pmid:8218344
Chen ZN et al. [Anti-platelet activating factor constituents, 2,5-diaryltetrahydrofuran type lignans, from Piper futokadsura Sied. et Zucc]. 1993 Zhongguo Zhong Yao Za Zhi pmid:8216803
Räisänen A et al. Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo. 1993 Transpl. Int. pmid:8216700
Tsai JJ et al. Enhanced eosinophil luminol-dependent chemiluminescence and complement receptor expression by platelet-activating factor and interleukin-5. 1993 Asian Pac. J. Allergy Immunol. pmid:8216559
Ko FN et al. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr. 1993 Biochem. Pharmacol. pmid:8216367
Damas J and Prunescu P Presence of immunoreactive platelet-activating factor in peritoneal exudate induced by zymosan in rats. 1993 Mar-Apr Arch Int Pharmacodyn Ther pmid:8215712
Miyagawa H et al. Density change of neutrophils from allergic subjects by granulocyte-macrophage colony stimulating factor. 1993 Ann Allergy pmid:8214805
Gaboury J et al. Nitric oxide prevents leukocyte adherence: role of superoxide. 1993 Am. J. Physiol. pmid:8214120
Kusano K et al. Metabolic polymorphism of E6123 in rhesus monkey. 1993 Xenobiotica pmid:8212734
Kusano K et al. Pharmacokinetics of a new thienodiazepine platelet activating factor receptor antagonist (E6123) in laboratory animals. Is there a metabolic polymorphism in the rhesus monkey? 1993 Xenobiotica pmid:8212733
Watson CJ et al. The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival. 1993 Transplantation pmid:8212192
Kald B et al. Phospholipase C from Clostridium perfringens stimulates acetyltransferase-dependent formation of platelet-activating factor in cultured intestinal epithelial cells (INT 407). 1994 Scand. J. Gastroenterol. pmid:8209184
Travis SP and Jewell DP The role of platelet-activating factor in the pathogenesis of gastrointestinal disease. 1994 Prostaglandins Leukot. Essent. Fatty Acids pmid:8208748
Anastasi EM et al. Disposition and metabolism of Ro 24-4736 in the rat. 1994 Life Sci. pmid:8208055
Gelbard HA et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. 1994 J. Virol. pmid:8207837
Bazan HE et al. Platelet-activating factor antagonists and ocular inflammation. 1994 J Ocul Pharmacol pmid:8207336
Simon HU et al. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. 1994 J. Immunol. pmid:8207248
Kusano K et al. Development of radioimmunoassay for the novel platelet activating factor receptor antagonist, E6123, and its application to pharmacokinetics in laboratory animals. 1994 Biol. Pharm. Bull. pmid:8205134
Nathan N et al. Serum platelet-activating factor acetylhydrolase during coronary artery bypass surgery. 1994 J. Cardiothorac. Vasc. Anesth. pmid:8204819
Sugiura T et al. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor. 1994 Arch. Biochem. Biophys. pmid:8203898
Rioux KP and Wallace JL Mast cell activation augments gastric mucosal injury through a leukotriene-dependent mechanism. 1994 Am. J. Physiol. pmid:8203531
Bazan NG et al. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. 1994 Proc. Natl. Acad. Sci. U.S.A. pmid:8202477
Lin CH et al. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol. 1994 J. Pharm. Pharmacol. pmid:8201527
Ambrosio G et al. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. 1994 J. Clin. Invest. pmid:8200975
Tashiro H et al. Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances. 1994 Dig. Dis. Sci. pmid:8200255
Tamura K et al. The effect of platelet-activating-factor antagonist TCV-309 on arrhythmias and functional recovery during myocardial reperfusion. 1994 Coron. Artery Dis. pmid:8199742
Hough SR and Parks JE Platelet-activating factor acetylhydrolase activity in seminal plasma from the bull, stallion, rabbit, and rooster. 1994 Biol. Reprod. pmid:8199270
Liapikos TA et al. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. 1994 Biochim. Biophys. Acta pmid:8199206
Kurosawa M et al. Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. 1994 Allergy pmid:8198242
Chávez-Cartaya RE et al. Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes. 1994 Transplantation pmid:8197604
Palmantier R et al. Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. 1994 Lab. Invest. pmid:8196365
Fukuda A et al. Platelet activating factor enhances the acrosome reaction, fertilization in vitro by subzonal sperm injection and resulting embryonic development in the rabbit. 1994 Hum. Reprod. pmid:8195361
Catto-Smith AG et al. Rat gastric motor response to food protein-induced anaphylaxis. 1994 Gastroenterology pmid:8194696
Cohen RA et al. A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization. 1994 Curr. Eye Res. pmid:8194360
Imanishi N et al. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride. 1994 Arzneimittelforschung pmid:8192697
Ou MC et al. Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure. 1994 Thromb. Res. pmid:8191415
Tatsumi N et al. An anti-platelet activating factor antibody and its effects on platelet aggregation. 1993 Osaka City Med J pmid:8183536
Orozco C et al. A description of the basic system of components in pregnant mice sera responsible for 'early pregnancy factor' activity. 1994 J. Reprod. Fertil. pmid:8182603
Alloatti G et al. Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction. 1994 J. Pharmacol. Exp. Ther. pmid:8182544
Goswami S et al. Characterization of a unique mucin-like glycoprotein secreted by a human endometrial adenocarcinoma cell line (Ishikawa). 1994 Jan-Feb Exp. Lung Res. pmid:8181454
Smith CS and Shearer WT Activation of NF-kappa B and immunoglobulin expression in response to platelet-activating factor in a human B cell line. 1994 Cell. Immunol. pmid:8181066
Blom M et al. Granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 greatly enhance the interaction of human eosinophils with opsonized particles by changing the affinity of complement receptor type 3. 1994 Blood pmid:8180394
Shirasaki H et al. Expression of platelet-activating factor receptor mRNA in human and guinea pig lung. 1994 Am. J. Respir. Cell Mol. Biol. pmid:8179916
Boyle T et al. Method for simultaneous isolation and quantitation of platelet activating factor and multiple arachidonate metabolites from small samples: analysis of effects of Staphylococcus aureus enterotoxin B in mice. 1994 Anal. Biochem. pmid:8179192
Barbier A et al. [Microcirculation and rheology]. 1994 Presse Med pmid:8177870
Demopoulos CA et al. A simple and precise method for the routine determination of platelet-activating factor in blood and urine. 1994 Lipids pmid:8177023
Gómez-Chiarri M et al. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. 1994 Lab. Invest. pmid:8176885